Skip to main content
. 2002 Jun 13;3:16. doi: 10.1186/1471-2091-3-16

Table 1.

Summary of inhibition data obtained for lerisetron, analog 1 and analog 2 on mutant and wildtype receptors. Ki values were calculated from IC50 values as previously described. All data is the result of n > 4 experiments and is expressed as the mean ± SE. The relative change in Ki was calculated as the Ki (mutant) / Ki (wildtype) and indicates the increase in Ki relative to wildtype ± SE. * indicates significant difference in fold change value. Kd values for [3H]granisetron binding to wt and mutant receptors were reproduced from reference 25.

Ligand [3H] Granisetron Lerisetron Analog 1 Analog 2
Amino acid Kd (nM) Fold change Ki (nM) Fold change Ki (nM) Fold change Ki (nM) Fold change
WT 0.98 ± 0.12 1 0.8 ± 0.19 1 25 ± 3.2 1 320 ± 82 1
W89F 5.7 ± 0.7 5.8 ± 0.7 3.8 ± 0.46 4.8 ± 0.56* 170 ± 54 7.0 ± 3.2* 1600 ± 400 5.1 ± 1.3*
W89Y 18 ± 2.0 18 ± 2.1 2.8 ± 0.14 3.5 ± 0.38* 81 ± 14 3.2 ± 0.6* 2200 ± 520 6.8 ± 1.6*
R91A 4.9 ± 0.7 5 ± 0.8 6.1 ± 1.16 7.6 ± 1.45* 22.7 ± 8 0.9 ± 0.28 180 ± 27 0.56 ± 0.14
Y140A 2.7 ± 0.2 2.8 ± 0.3 2.1 ± 0.33 2.6 ± 0.37 88 ± 45 3.5 ± 1.7 470 ± 210 1.4 ± 0.65
Y142A 4.5 ± 0.5 4.6 ± 0.5 130 ± 28 160 ± 37 170 ± 58 6.8 ± 2.3* 5500 ± 240 17 ± 0.77
Y152A 7.8 ± 1.1 8 ± 1.1 150 ± 36 190 ± 43 2500 ± 400 98 ± 16 13000 ± 4200 40 ± 12
HHS Vulnerability Disclosure